Vascular α-adrenoceptors: From the gene to the human

Canadian Journal of Physiology and Pharmacology

Volumn 73, Issue 5, 1995, Pages 533-543

  Bylund, D B ^a   Regan, J W ^a   Faber, J E ^a   Hieble, J P ^a   Triggle, C R ^a   Ruffolo Jr , R R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

adrenoceptor subclassification; G proteins; second messenger; smooth muscle proliferation; vasoconstriction

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 BROMO 7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYLFURO[4,3,2 EF][3]BENZAZEPINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 6 METHYL 8BETA [(2 PHENYL 1 IMIDAZOLYL)METHYL]ERGOLINE; 7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYL 2 VINYLTHIENO[4,3,2 EF][3]BENZAZEPINE; ALPHA ADRENERGIC RECEPTOR; DOBUTAMINE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NIGULDIPINE; NORADRENALIN; OXYMETAZOLINE; PHENTOLAMINE; PRAZOSIN; RAUWOLSCINE; SKF 105854; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0029123209     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y95-068     Document Type: Conference Paper

References (0)